Profile picture

Doctor Hung-Yu Chang

Cheng-Hsin General Hospital, Taipei (Taiwan)
Follow
Biography
Dr Hung-Yu Chang is an attending physician of Cardiology at Cheng Hsin General Hospital in Taipei, Taiwan. She has a special interest in interventional cardiology, electrophysiology and heart failure.
Logo ESC

Contributor content

Trends in guideline-directed medical therapy and clinical outcomes in Taiwanese heart failure patients: insight from the TSOC HF registry 2020
Presentation
Trends in guideline-directed medical therapy and clinical outcomes in Taiwanese heart failure patients: insight from the TSOC HF registry 2020
Effects of mask-wearing on treadmill exercise test
Presentation
Effects of mask-wearing on treadmill exercise test
Angiotensin receptor neprilysin inhibition in reduced ejection fraction patients with advanced chronic kidney disease: a multicenter propensity score matching study
Presentation
Angiotensin receptor neprilysin inhibition in reduced ejection fraction patients with advanced chronic kidney disease: a multicenter propensity score matching study
The effects of sacubitril/valsartan on cardiac resynchronization therapy candidates
Presentation
The effects of sacubitril/valsartan on cardiac resynchronization therapy candidates
Twin peaks diversity with sacubitril/valsartan treatment responses in cardiomyopathic heart failure patients of non-ischemic compared to ischemic etiologies
Presentation
Twin peaks diversity with sacubitril/valsartan treatment responses in cardiomyopathic heart failure patients of non-ischemic compared to ischemic etiologies
Sacubitril/valsartan in heart failure with reduced ejection fraction patients: real world experience on advanced chronic kidney disease, hypotension and dose titration
Presentation
Sacubitril/valsartan in heart failure with reduced ejection fraction patients: real world experience on advanced chronic kidney disease, hypotension and dose titration
Recovery of left ventricular dysfunction after Sacubitril/valsartan: predictors and managements
Presentation
Recovery of left ventricular dysfunction after Sacubitril/valsartan: predictors and managements
Twin peaks diversity with sacubitril/valsartan treatment responses in cardiomyopathic heart failure patients of non-ischemic compared to ischemic etiologies
Presentation
Twin peaks diversity with sacubitril/valsartan treatment responses in cardiomyopathic heart failure patients of non-ischemic compared to ischemic etiologies

ESC 365 is supported by